One participant in the drug trial for Journavx said it eliminated her pain without making her feel loopy or nauseous, which ...
The opioid epidemic continues to affect hundreds of thousands of people, but there may be hope for the future with a new, non ...
The Food and Drug Administration (FDA) is hoping a newly approved non-opioid pain medication could help save lives. Dr.
Introducing Journavx: the FDA-approved non-opioid, non-addictive drug for acute pain. A major breakthrough in pain medication ...
The new Center for Recovery and Wellbeing and a Pathways to Recovery website seeks to break down barriers for those fighting addiction.
The Food and Drug Administration Jan. 30 announced it approved Journavx (suzetrigine) oral tablets, a first-in-class ...
A non-opioid pain medication made by Vertex Pharmaceuticals has received approval for adults from the Food and Drug ...
Research reveals that δ-receptor agonists like KNT-127 alleviate IBS symptoms by modulating gut-brain interactions and ...
Patients seeking an opioid-free way to handle pain experienced in the short-term will soon have a new option.
The Phase IIa results continue a surge of momentum in a treatment space that last week saw the approval of Vertex’s Journavx ...
Vertex has gained the FDA's approval for its nonaddictive pain med Journavx, which becomes the first significant innovation ...
More than 81,000 people in 2023 died in overdoses that involved opioids, according to federal data. According to the FDA, Journavx “reduces pain by targeting a pain-signaling pathway involving ...